HSCS (HeartSciences) ROE % Adjusted to Book Value : -209.97% (As of Jul. 2024)

View and export this data going back to 2022. Start your Free Trial

What is HeartSciences ROE % Adjusted to Book Value?

HeartSciences's ROE % for the quarter that ended in Jul. 2024 was -123.88%. HeartSciences's PB Ratio for the quarter that ended in Jul. 2024 was 0.59. HeartSciences's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2024 was -209.97%.

HeartSciences ROE % Adjusted to Book Value Historical Data

The historical data trend for HeartSciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeartSciences ROE % Adjusted to Book Value Chart

HeartSciences Annual Data

Trend

Apr20

Apr21

Apr22

Apr23

Apr24

ROE % Adjusted to Book Value

-205.89

HeartSciences Quarterly Data
	Apr20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial											-	-	-171.20	-108.92	-209.97

Competitive Comparison of HeartSciences's ROE % Adjusted to Book Value

For the Medical Devices subindustry, HeartSciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeartSciences's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeartSciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where HeartSciences's ROE % Adjusted to Book Value falls into.

HeartSciences ROE % Adjusted to Book Value Calculation

HeartSciences's ROE % Adjusted to Book Value for the fiscal year that ended in Apr. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-175.01%	/	0.85
	=	-205.89%

HeartSciences's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-123.88%	/	0.59
	=	-209.97%

HeartSciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of HeartSciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

HeartSciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeartSciences Inc (NAS:HSCS) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

550 Reserve Street, Suite 360, Southlake, TX, USA, 76092

Website

https://www.heartsciences.com

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Executives

David R. Wells	director	2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent	director	750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz	director, officer: See Remarks	3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff	director	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak	director	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson	officer: See Remarks	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson	director, officer: See Remarks	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092